Most Read Articles
Popular Stories
RADAR on Medicare Advantage
-
A seemingly routine discussion of inefficiencies in Texas Medicaid procurement took a shocking turn last week when the committee’s chair accused Superior HealthPlan CEO Mark Sanders of hiring private investigators to...
-
The Medicare Payment Advisory Commission’s (MedPAC) scrutiny of Medicare Advantage’s financial status continued in its March 2025 Report to the Congress: Medicare Payment Policy. The commission estimated that...
HEALTH PLAN WEEKLY
-
During his mid-March confirmation hearing before the Senate Finance Committee, Mehmet Oz, M.D., expressed tentative interest in an idea floated by a Democratic senator: expanding the often-overlooked Basic...
-
The “well-intentioned” Inflation Reduction Act (IRA) of 2022 could cause more harm than good in the world of payers, pharmacies and drug development, according to experts who spoke at the 2025 Academy of Managed...
Radar On Speciality Pharmacy
-
The cell and gene therapy (CGT) space seems to be a bit of a mixed bag recently. While last year’s accomplishments included FDA approvals of two new first-in-class treatments for solid tumors and the first...
-
As CMS undergoes its pricing negotiations on the second round of drugs under the Medicare Drug Price Negotiation Program, a recent report reveals that manufacturer concerns over the program’s potential threat...
RADAR ON DRUG BENEFITS
-
The America First Policy Institute, a think tank founded by former advisers to President Donald Trump, recently released a paper that blamed foreign countries for pharmaceutical “global freeloading” and outlined...
-
Optum Rx’s new pharmacy reimbursement model, which the UnitedHealth Group-owned PBM unveiled on March 20, has been met with mixed reviews. One Wall Street analyst suggested the move could benefit both...
About AIS Health
AIS Health is a publishing and information company that has served the health care industry for more than 30 years. Our mission is to provide our readers with an actionable understanding of the business of health care and pharmaceuticals. Our in-depth writing covers the companies, people, catalysts and trends that create the richly textured contours of the health care and drug industry. AIS Health maintains journalistic independence from our parent company, MMIT. We are committed to integrity in reporting and bringing transparency to health industry data.
The Latest
Complimentary Publications
Premium Categories
Premium Categories
Get an actionable understanding of the business of health care and pharmaceuticals
Sign up for publications to get unmatched business intelligence delivered to your inbox.